Manufacturing

  1. Connect And Disconnect Aseptically Using Sterile Connection Technology 5/18/2022

    In this video, we review how assembling is a quick and easy three-step process - flip, click, and pull. See how to follow these steps to ensure a secure, leak-free connection.

  2. Inoculation In The PBS Mini 8/4/2025

    Learn how to inoculate the PBS Mini bioreactor. Discover best practices for adding supplements and cells, ensuring gentle handling and optimal mixing for your cell culture.

  3. Explore The M Lab Collaboration Center In Burlington MA 9/19/2022

    Our global network of scientific experts, innovative technologies, and non-GMP facilities, empower drug developers of all sizes to achieve manufacturing excellence and innovation through collaborative exploration and learning. Explore 1 of our 8 global facilities today.

  4. Microcarrier Separation Systems 11/3/2022

    Ross Acucena, applications director, and Donnie Beers, product manager, introduce our highly functional and adaptable microcarrier cell separation bags designed for single-use processes. 

  5. Freezing Studies For Single-Use Solutions: Long-Term (Part 2) 5/14/2024

    Watch part 2 of a four-part series, "Four Common Types Of Cryogenic Studies For Advanced Therapies," to learn about long-term freezing studies.

  6. Inside An Onsite Test Lab 10/13/2022

    Learn about the extensive testing and validation to ensure product performance based on risk assessments performed under CPC’s ISO 13485 quality system, streamlining approval processes and allowing manufacturers to reach market faster and with less work.

  7. SF-RVN® Platform For Improving The Safety Profile Of Your Therapies 7/19/2022

    Discover how our Insect Cell Line provides a high performance platform optimal to produce recombinant proteins, viral vaccines, and adeno-associated vectors (AAV) for gene therapy applications.

  8. Executive Roundtable: Cell Therapy Predictions For 2025 And Beyond 12/17/2024

    In this executive roundtable discussion, Bioprocess Online editor Tyler Menichiello is joined by CEO, co-founder, and president of Ossium Health, Kevin Caldwell, CSO of FibroBiologics, Hamid Khoja, Ph.D., and president and acting CEO of Triumvira Immunologics, Rob Williamson. The panelists share their predictions and thoughts on the industry’s direction heading into 2025. They cover manufacturing trends (noting opportunities for improvements in cell therapy manufacturing), AI adoption, regulatory concerns, and the potentially challenging funding environment ahead. 

  9. Key Functions Of The ÄKTA Oligosynt Synthesizer 2/16/2023

    Discover a compact, fully automated oligonucleotide synthesizer for robust, scalable process development. Learn how it can help establish a robust and reproducible oligo synthesis process.

  10. Ori Spotlight: How Early Automation Strategies Reduce Costs And Improve Patient Access 6/20/2025

    A pioneer in regenerative medicine reveals how to bridge the gap from research to reality. Learn how early automation and strategic partnerships can slash costs and expand patient access to therapies.